HLA-C and neoplasm: With LOHHLA analysis demonstrating intact HLA-A*11:01 in this organoid (Fig. 5b), this again suggested decreased MHC-peptide complex on the tumor surface due to insufficient expression of the KRAS G12D allele or a defect in its processing and loading onto MHC.